Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
Journal of Medicinal Food|May 11, 2011
Effect of Shengmai-san on cognitive performance and cerebral oxidative damage in BALB/c miceVijayasree V Giridharan, Rajarajan A Thandavarayan, Tetsuya KonishiCardiology Clinics|April 15, 2020
Pathophysiology of Acute and Chronic Right Heart FailureRajarajan A Thandavarayan, Kalyan R Chitturi, Ashrith GuhaJournal of Diabetes Research|November 25, 2016
ALDH2 Inhibition Potentiates High Glucose Stress-Induced Injury in Cultured CardiomyocytesGuodong Pan, Mandar Deshpande, Rajarajan A Thandavarayan, et al.Antioxidants & Redox Signaling|April 11, 2018
Transflammation: How Innate Immune Activation and Free Radicals Drive Nuclear ReprogrammingShu Meng, Palas Chanda, Rajarajan A Thandavarayan, et al.Cardiovascular & Hematological Agents in Medicinal Chemistry|September 10, 2011
Diabetic cardiomyopathy and oxidative stress: role of antioxidantsRajarajan A Thandavarayan, Vijayasree V Giridharan, Kenichi Watanabe, et al.Advanced Drug Delivery Reviews|September 17, 2017
Transflammation: Innate immune signaling in nuclear reprogrammingShu Meng, Palas Chanda, Rajarajan A Thandavarayan, et al.Heart Failure Reviews|November 26, 2021
Right ventricular failure: a comorbidity or a clinical emergency?Pamelika Das, Rajarajan A Thandavarayan, Kenichi Watanabe, et al.Drug Discovery Today|February 25, 2016
Targeting fatty acid metabolism in heart failure: is it a suitable therapeutic approach?Somasundaram Arumugam, Remya Sreedhar, Rajarajan A Thandavarayan, et al.Frontiers in Pharmacology|July 11, 2022
An <i>In Vitro</i> Platform to Study Reversible Endothelial-to-Mesenchymal TransitionMuthu Kumar Krishnamoorthi, Rajarajan A Thandavarayan, Keith A Youker, et al.Drug Discovery Today|March 21, 2016
Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel diseaseRemya Sreedhar, Somasundaram Arumugam, Rajarajan A Thandavarayan, et al.Pageof 11